Fig. 2From: Treatment of gastrointestinal tumor (GIST) of the rectum requiring abdominoperineal resection following neoadjuvant imatinib: a cost-effectiveness analysisOne way sensitivity analysis evaluating incremental cost effectiveness ratios (ICERs) of UAPR compared with CIUP for a range of utilities associated with abdominoperineal resectionBack to article page